Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2025
    • ACR Convergence 2025
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2025
    • ACR Convergence 2025
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023

Index by author

September 01, 2011; Volume 78,Issue 9
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Alraies, M. Chadi

    1. You have access
      Unmasking gastric cancer
      Faysal Altahawi, Abdul Hamid Alraiyes, MD and M. Chadi Alraies, MD, FACP
      Cleveland Clinic Journal of Medicine September 2011, 78 (9) 606-608; DOI: https://doi.org/10.3949/ccjm.78a.10129

      Screening with diagnostic imaging may be justified in high-risk groups, although the issue is debatable.

  2. Alraiyes, Abdul Hamid

    1. You have access
      Unmasking gastric cancer
      Faysal Altahawi, Abdul Hamid Alraiyes, MD and M. Chadi Alraies, MD, FACP
      Cleveland Clinic Journal of Medicine September 2011, 78 (9) 606-608; DOI: https://doi.org/10.3949/ccjm.78a.10129

      Screening with diagnostic imaging may be justified in high-risk groups, although the issue is debatable.

  3. Altahawi, Faysal

    1. You have access
      Unmasking gastric cancer
      Faysal Altahawi, Abdul Hamid Alraiyes, MD and M. Chadi Alraies, MD, FACP
      Cleveland Clinic Journal of Medicine September 2011, 78 (9) 606-608; DOI: https://doi.org/10.3949/ccjm.78a.10129

      Screening with diagnostic imaging may be justified in high-risk groups, although the issue is debatable.

  4. Dao, Carol

    1. You have access
      Oral plaques and dysphagia in a young man
      Amber S. Tully, MD and Carol Dao, MD
      Cleveland Clinic Journal of Medicine September 2011, 78 (9) 594-596; DOI: https://doi.org/10.3949/ccjm.78a.10150

      A 23-year-old man presents with oral plaques, a sore throat, dysphagia, malaise, and weight loss. What is the most likely diagnosis?

  5. Hsieh, Fred H.

    1. You have access
      Allergy blood testing: A practical guide for clinicians
      Roxana I. Siles, MD and Fred H. Hsieh, MD
      Cleveland Clinic Journal of Medicine September 2011, 78 (9) 585-592; DOI: https://doi.org/10.3949/ccjm.78a.11023

      These tests can confirm the diagnosis of an allergic disorder, supplementing the clinical history. They are particularly useful when skin testing cannot or should not be done.

  6. Kaatz, Scott

    1. You have access
      Venous thromboembolism: What to do after anticoagulation is started
      Scott Kaatz, DO, MSc, FACP, Waqas Qureshi, MD and Robert C. Lavender, MD, FACP
      Cleveland Clinic Journal of Medicine September 2011, 78 (9) 609-618; DOI: https://doi.org/10.3949/ccjm.78a.10175

      Three issues need to be addressed: the length of therapy, measures to prevent postthrombotic syndrome, and a basic workup for possible underlying malignancy.

  7. Lavender, Robert C.

    1. You have access
      Venous thromboembolism: What to do after anticoagulation is started
      Scott Kaatz, DO, MSc, FACP, Waqas Qureshi, MD and Robert C. Lavender, MD, FACP
      Cleveland Clinic Journal of Medicine September 2011, 78 (9) 609-618; DOI: https://doi.org/10.3949/ccjm.78a.10175

      Three issues need to be addressed: the length of therapy, measures to prevent postthrombotic syndrome, and a basic workup for possible underlying malignancy.

  8. Longworth, David L.

    1. You have access
      Accountable care organizations, the patient-centered medical home, and health care reform: What does it all mean?
      David L. Longworth, MD
      Cleveland Clinic Journal of Medicine September 2011, 78 (9) 571-582; DOI: https://doi.org/10.3949/ccjm.78gr.11003

      Central to fixing the broken US health care system are two concepts: the patient-centered medical home and accountable care organizations.

  9. Mandell, Brian F.

    1. You have access
      When to stop treating the bones
      Brian F. Mandell, MD, PhD
      Cleveland Clinic Journal of Medicine September 2011, 78 (9) 563; DOI: https://doi.org/10.3949/ccjm.78b.11009

      Don’t let the argument about how long to treat osteoporosis with bisphosphonate drugs stand in the way of initiating therapy in patients at risk of fracture.

  10. Ott, Susan M.

    1. What is the optimal duration of bisphosphonate therapy?
      You have access
      What is the optimal duration of bisphosphonate therapy?
      Susan M. Ott, MD
      Cleveland Clinic Journal of Medicine September 2011, 78 (9) 619-630; DOI: https://doi.org/10.3949/ccjm.78a.11022

      It is reasonable to stop bisphosphonates after 5 years of use and then to follow patients with markers of bone turnover.

« Previous (Pages : 1 2 ... 2) Next »
Back to top
PreviousNext

In this issue

Cleveland Clinic Journal of Medicine: 78 (9)
Cleveland Clinic Journal of Medicine
Vol. 78, Issue 9
1 Sep 2011
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Sign up for alerts
  • Editor's Picks
  • Most Cited
  • Most Read
Loading
A new direction in pain management?
Profound xanthomas in a young man
Xanthomas: A clue to undiagnosed lipid disorders
A young woman with Kallmann syndrome and acute neurologic symptoms
Multicentric reticulohistiocytosis
Finding the cause of severe hypokalemia: A 4-step approach
How should I incorporate emergency contraception counseling into my practice?
Acute transient phlebitis after a morphine infusion
Rethinking recovery in heart failure: Beyond improvement in left ventricular ejection fraction
Failure to thrive in hospitalized older adults: More than a ‘social admission’
What is the optimal time for bone density screening in patients with premature ovarian insufficiency?

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2026 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire